莫匹罗星结构式
|
常用名 | 莫匹罗星 | 英文名 | Mupirocin |
---|---|---|---|---|
CAS号 | 12650-69-0 | 分子量 | 500.622 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 672.3±55.0 °C at 760 mmHg | |
分子式 | C26H44O9 | 熔点 | 77-780C | |
MSDS | 中文版 美版 | 闪点 | 216.5±25.0 °C |
莫匹罗星用途莫匹罗星(Mupirocin)是一抗生素化合物。 |
中文名 | 莫匹罗星 |
---|---|
英文名 | mupirocin |
中文别名 | 假单胞菌酸 | 莫西罗星 |
英文别名 | 更多 |
描述 | 莫匹罗星(Mupirocin)是一抗生素化合物。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 672.3±55.0 °C at 760 mmHg |
熔点 | 77-780C |
分子式 | C26H44O9 |
分子量 | 500.622 |
闪点 | 216.5±25.0 °C |
精确质量 | 500.298523 |
PSA | 146.05000 |
LogP | 3.44 |
外观性状 | 固体 |
蒸汽压 | 0.0±4.7 mmHg at 25°C |
折射率 | 1.524 |
储存条件 | -20°C Freezer, Under Inert Atmosphere |
水溶解性 | H2O: 12 mg/mL, soluble |
分子结构 | 1、 摩尔折射率:129.51 2、 摩尔体积(cm3/mol):423.0 3、 等张比容(90.2K):1119.6 4、 表面张力(dyne/cm):49.0 5、 极化率(10-24cm3):51.34 |
计算化学 | 1.疏水参数计算参考值(XlogP):3 2.氢键供体数量:4 3.氢键受体数量:9 4.可旋转化学键数量:17 5.互变异构体数量:无 6.拓扑分子极性表面积146 7.重原子数量:35 8.表面电荷:0 9.复杂度:694 10.同位素原子数量:0 11.确定原子立构中心数量:8 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:1 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1.性状:从乙醚结晶,熔点77~78℃。 2.比旋光度:[α]D20-19.3°(C=1,甲醇)。 3.UV最大吸收(乙醇):222nm(ε14500)。 |
莫匹罗星上游产品 10 | |
---|---|
莫匹罗星下游产品 0 |
由荧光假单胞菌产生的一类物质,包括假单胞菌酸A、B、C、D,莫匹罗星即其中的主要代谢物假单胞菌酸A。
海关编码 | 2941909000 |
---|
Purification and characterization of the Staphylococcus aureus bacillithiol transferase BstA.
Biochim. Biophys. Acta 1840(9) , 2851-61, (2014) Gram-positive bacteria in the phylum Firmicutes synthesize the low molecular weight thiol bacillithiol rather than glutathione or mycothiol. The bacillithiol transferase YfiT from Bacillus subtilis wa... |
|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
J. Sci. Ind. Res. 65(10) , 808, (2006) Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ... |
|
Simultaneous monitoring of Staphylococcus aureus growth in a multi-parametric microfluidic platform using microscopy and impedance spectroscopy.
Bioelectrochemistry 105 , 56-64, (2015) We describe the design, construction, and characterization of a scalable microfluidic platform that allows continuous monitoring of biofilm proliferation under shear stress conditions. Compared to oth... |
Pseudomonic acid |
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxy-2-butanyl]-2-oxiranyl}methyl)tetrahydro-2H-pyran-2-yl]-3-methyl-2-butenoyl}oxy)nonanoic acid |
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid (non-preferred name) |
Bactoderm |
MFCD03792664 |
Pseudomonic acid A |
Mupirocin |
EINECS 231-791-2 |
Turixin |
BACTROBAN |
Mupirocin [USAN:BAN:INN] |
Mupirocina |
trans-Pseudomonic Acid |
Bactroban Nasal |
Plasimine |
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid |
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid (non-preferred name) |
Mupirocine |
Mupirocinum |
[2S-[2a(E),3b,4b,5a[2R*,3R*(1R*,2R*)]]]-9-[[3-Methyl-1-oxo-4-[tetrahydro-3,4-dihydroxy-5-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-2H-pyran-2-yl]-2-butenyl]oxy]nonanoic Acid |
Centany |
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid |